NOUVEAUX DERIVES DE THIAZOLIDINE-2,4-DIONE SUBSTITUES, LEURS PROCEDES D'OBTENTION ET LES COMPOSITIONS PHARMACEUTIQUES EN RENFERMANT
    5.
    发明授权
    NOUVEAUX DERIVES DE THIAZOLIDINE-2,4-DIONE SUBSTITUES, LEURS PROCEDES D'OBTENTION ET LES COMPOSITIONS PHARMACEUTIQUES EN RENFERMANT 失效
    取代噻唑烷二酮衍生物,其制备和药物组合物含有它们

    公开(公告)号:EP0918759B1

    公开(公告)日:2002-08-28

    申请号:EP97925034.7

    申请日:1997-06-02

    申请人: MERCK PATENT GmbH

    IPC分类号: C07D277/34

    CPC分类号: C07D277/34

    摘要: The invention relates to the field of chemistry and more particularly to that of therapeutic chemistry. The invention more precisely features novel 5-phenoxyalkyl 2,4-thiazolidinediketones of general formula (I): in which A represents one linear or branched alkylene group comprising 2 to 16 carbon atoms D represents one monocyclic, bycyclic or tricyclic, homocarbonaceous or heterocarbonaceous aromatic structure capable of enclosing one or several heteroatoms X represents the aromatic structure substituent and is as defined in claim 1 n is one integer ranging from 1 to 3 with the restriction that if A represents one butyl radical, (a) does not represent the 4-chlorophenyl group. The invention also disclosed tautomer, enantiomer, diastereoisomer and epimer forms of general formula (I) compounds, in free or salified form. The invention also discloses methods for obtaining general formula (I) compounds, their use as antidiabetic agents, and in the insulin resistance metabolic syndrome, as well as in the pharmaceutical compositions that contain general formula (I) compounds.